Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.
Department of Pathology, NYU Langone Health, New York, NY, USA.
Nat Commun. 2024 Aug 28;15(1):7425. doi: 10.1038/s41467-024-51492-6.
Relapsed pediatric B-cell acute lymphoblastic leukemia (B-ALL) remains one of the leading causes of cancer mortality in children. We performed Hi-C, ATAC-seq, and RNA-seq on 12 matched diagnosis/relapse pediatric leukemia specimens to uncover dynamic structural variants (SVs) and 3D chromatin rewiring that may contribute to relapse. While translocations are assumed to occur early in leukemogenesis and be maintained throughout progression, we discovered novel, dynamic translocations and confirmed several fusion transcripts, suggesting functional and therapeutic relevance. Genome-wide chromatin remodeling was observed at all organizational levels: A/B compartments, TAD interactivity, and chromatin loops, including some loci shared by 25% of patients. Shared changes were found to drive the expression of genes/pathways previously implicated in resistance as well as novel therapeutic candidates, two of which (ATXN1 and MN1) we functionally validated. Overall, these results demonstrate chromatin reorganization under the selective pressure of therapy and offer the potential for discovery of novel therapeutic interventions.
复发型儿科 B 细胞急性淋巴细胞白血病 (B-ALL) 仍然是儿童癌症死亡的主要原因之一。我们对 12 对匹配的诊断/复发儿科白血病标本进行了 Hi-C、ATAC-seq 和 RNA-seq 分析,以揭示可能导致复发的动态结构变异 (SV) 和 3D 染色质重排。虽然易位被认为发生在白血病发生的早期,并在整个进展过程中保持,但我们发现了新的、动态的易位,并证实了几个融合转录本,表明其具有功能和治疗相关性。在所有组织水平上都观察到了全基因组染色质重塑:A/B 区室、TAD 相互作用和染色质环,包括 25%的患者共有的一些基因座。共享的变化被发现可以驱动先前与耐药性相关的基因/途径的表达,以及新的治疗候选物,其中两个(ATXN1 和 MN1)我们进行了功能验证。总的来说,这些结果表明在治疗的选择性压力下染色质重新组织,并为发现新的治疗干预提供了潜力。